/
/
/

TruAlt Bioenergy Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
----9%
----34%
----17%
23%23%23%8%

Peer Comparison

Symbol
UNITDSPR
RADICO
UBL
ABDL
TI
PICCADIL
TRUALT
INDIAGLYCO
GLOBUSSPR
GMBREW
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,419.3₹100302 Cr54.285.929.59₹1838 Cr
4,396.5₹56932 Cr71.4917.3471.66₹604 Cr
1,204.5₹31464 Cr64.955.1230.42₹413 Cr
699.9₹19426 Cr85.132.5611.32₹228 Cr
473.6₹11489 Cr—0.93.64₹21 Cr
598₹5775 Cr41.092.1717.11₹138 Cr
372.4₹3082 Cr13.944.0436.72₹96 Cr
309.45₹2172 Cr6.8714.4571.58₹293 Cr
669.1₹2071 Cr22.334.5161.68₹92 Cr
832.7₹1807 Cr11.5217.1970.92₹157 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
₹811 Cr₹627 Cr₹596 Cr₹713 Cr₹115 Cr₹304 Cr₹907 Cr₹415 Cr₹388 Cr₹197 Cr
₹13 Cr₹15 Cr₹31 Cr₹18 Cr₹15 Cr₹23 Cr₹14 Cr₹15 Cr₹17 Cr₹15 Cr
₹824 Cr₹641 Cr₹627 Cr₹731 Cr₹130 Cr₹327 Cr₹921 Cr₹431 Cr₹405 Cr₹212 Cr
₹734 Cr₹519 Cr₹500 Cr₹601 Cr₹140 Cr₹283 Cr₹771 Cr₹308 Cr₹387 Cr₹199 Cr
₹114 Cr₹147 Cr₹150 Cr₹152 Cr₹10 Cr₹64 Cr₹167 Cr₹140 Cr₹34 Cr₹29 Cr
₹42 Cr₹44 Cr₹44 Cr₹40 Cr₹39 Cr₹38 Cr₹39 Cr₹36 Cr₹34 Cr₹35 Cr
₹47 Cr₹78 Cr₹84 Cr₹90 Cr-₹49 Cr₹6 Cr₹111 Cr₹86 Cr-₹16 Cr-₹22 Cr
₹35 Cr₹59 Cr₹61 Cr₹69 Cr-₹38 Cr₹5 Cr₹112 Cr₹75 Cr-₹19 Cr-₹22 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024
———
₹86 Cr₹71 Cr₹208 Cr
₹1435 Cr₹698 Cr₹57 Cr
₹1435 Cr₹698 Cr₹57 Cr
₹1520 Cr₹769 Cr₹265 Cr
₹58 Cr₹0₹0
₹989 Cr₹1117 Cr₹980 Cr
₹111 Cr₹80 Cr₹105 Cr
₹11 Cr₹13 Cr₹6 Cr
₹5 Cr₹3 Cr₹2 Cr
₹1115 Cr₹1213 Cr₹1092 Cr
———
₹272 Cr₹486 Cr₹154 Cr
₹378 Cr₹282 Cr₹335 Cr
₹435 Cr₹279 Cr₹573 Cr
₹31 L₹25 L₹15 L
₹1085 Cr₹1048 Cr₹1061 Cr
₹3778 Cr₹3030 Cr₹2418 Cr
₹1646 Cr₹1550 Cr₹1685 Cr
———
₹2416 Cr₹1970 Cr₹1504 Cr
₹231 Cr₹145 Cr₹78 Cr
₹2185 Cr₹1826 Cr₹1427 Cr
₹68 Cr₹3 Cr₹201 Cr
₹21 Cr₹137 Cr₹132 Cr
₹26 Cr₹2 Cr₹56 L
₹2300 Cr₹1968 Cr₹1760 Cr
———
₹4 Cr₹4 Cr₹10 Cr
₹528 Cr₹210 Cr₹159 Cr
₹406 Cr₹339 Cr₹298 Cr
₹90 Cr₹150 Cr₹23 Cr
₹152 Cr₹123 Cr₹63 Cr
₹298 Cr₹235 Cr₹104 Cr
₹1479 Cr₹1062 Cr₹658 Cr
₹394 Cr₹15 Cr-₹403 Cr
₹3778 Cr₹3030 Cr₹2418 Cr
₹177₹109₹19
₹177₹109₹19

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024
₹130 Cr₹159 Cr₹45 Cr
₹236 Cr₹198 Cr₹201 Cr
-₹654 Cr-₹18 Cr-₹207 Cr
-₹287 Cr₹340 Cr₹39 Cr
-₹296 Cr₹342 Cr₹35 Cr
-₹413 Cr-₹255 Cr-₹384 Cr
₹648 Cr₹40 Cr₹367 Cr
-₹62 Cr₹126 Cr₹19 Cr
₹150 Cr₹23 Cr₹5 Cr
₹88 Cr₹150 Cr₹23 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)365.00
Volume (₹)1.11 L
High (₹)375.00
Upper Circuit431.55
Low (₹)362.65
Lower Circuit287.75
Prev Close359.65
52W High (₹)542.00
Price372.40
52W Low (₹)310.20

Share Market Cap & Key Ratios Overview

M.Cap (₹)3081.52 Cr
Div. Yield (%)0.00
PE Ratio13.94
Debt to Equity1.08
Price to Book2.26
Book Value177.29
EPS (TTM)25.78
Face Value10.00
ROE (%)8.46

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
UNITDSPRNSE
RADICONSE
UBLNSE
ABDLNSE
TINSE
PICCADILNSE
TRUALTNSE
INDIAGLYCONSE
GLOBUSSPRNSE
GMBREWNSE
LTP
1W Low
1W High
Market cap (₹)
1419.3+85.6 (6.42%)
1328.70
1419.30
1,00,302Cr
4396.5+309.8 (7.58%)
4056.70
4396.50
56,932Cr
1204.5+24.2 (2.05%)
1169
1215
31,464Cr
699.9+1.65 (0.24%)
676
728.40
19,426Cr
473.6-7.25 (-1.51%)
436.75
486.85
11,489Cr
598+39.65 (7.10%)
550.85
601.80
5,775Cr
372.4+12.8 (3.56%)
356.25
379.80
3,082Cr
309.45-22.25 (-6.71%)
304
337.45
2,172Cr
669.1-9.8 (-1.44%)
656
685.05
2,071Cr
832.7+46.9 (5.97%)
776
835
1,807Cr

TruAlt Bioenergy Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹147.28Cr; with other income of ₹14.53Cr, profit before interest and tax came to ₹122.48Cr. Interest expense was ₹44.03Cr; PBT before exceptional items stood at ₹78.44Cr. Cost mix (full year): raw materials ₹1257.11Cr; employee cost ₹47.82Cr; depreciation ₹24.8Cr; other expenses ₹494.13Cr. Basis: consolidated annual results.

TruAlt Bioenergy Ltd Quaterly Results Key Takeaways

TruAlt Bioenergy Ltd reported ₹626.88Cr total income from operations in Jun 2026, softer than ₹595.52Cr in Mar 2026 but higher than ₹303.89Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹147.28Cr; with other income of ₹14.53Cr, profit before interest and tax came to ₹122.48Cr. Interest expense was ₹44.03Cr, taking profit before tax to ₹78.44Cr. After tax of ₹19.17Cr, profit after tax stood at ₹59.27Cr (vs ₹60.95Cr in Mar 2026 and ₹4.72Cr in Jun 2025).